Heparin-induced thromboembolism: a case report.

Area of Science:

• Vascular Medicine
• Hematology

Background:

• Heparin is a common anticoagulant used to prevent and treat thromboembolic events.
• Heparin-induced thrombocytopenia (HIT) is a rare but serious immune-mediated complication characterized by thrombocytopenia and a prothrombotic state.

Observation:

• This case report details a patient who developed thrombosis of the brachial artery concurrently with thrombocytopenia.
• The patient was receiving heparin therapy at the time of the event.

Findings:

• Discontinuation of heparin led to a normalization of circulating platelet volumes.
• This suggests a causal link between heparin administration and the observed clinical manifestations.

Implications:

• The findings highlight the importance of recognizing heparin-induced thrombosis with thrombocytopenia (HITT) in patients presenting with arterial thrombosis and low platelet counts.
• Further research is needed to elucidate the role of pre-existing arterial disease and sepsis in the pathogenesis of HITT.
• Prompt diagnosis and cessation of heparin are crucial for managing this condition and preventing further thrombotic complications.